热门资讯> 正文

Immix Bizerma定价1.25亿美元股票发行

2026-09-29 19:33

Immix Biopharma(IMMX) 0

Immix Biopharma (IMMX) said it priced an underwritten registered offering of 11.36M shares of common stock at $11 per share, with gross proceeds expected to reach $125M .
The offering is expected to close around Sept. 30, 2026, subject to customary closing conditions. Immix plans to use the net proceeds to fund the development of NXC-201, as well as for working capital and general corporate purposes.

More on Immix Biopharma, Inc.

Immix Biopharma exec fired following arrest after 20 years on the run
Seeking Alpha’s Quant Rating on Immix Biopharma, Inc.
Historical earnings data for Immix Biopharma, Inc.
Financial information for Immix Biopharma, Inc.

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。